🇺🇸 FDA
Pipeline program

Elagolix

M12-673

Phase 1 small_molecule completed

Quick answer

Elagolix for Folliculogenesis is a Phase 1 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
NEUROCRINE BIOSCIENCES INC
Indication
Folliculogenesis
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials